Gulf Pharmaceutical Industries (Julphar) announced its full-year financial results for the year ended December 31, 2025, recording strong revenue growth and a significant improvement in profitability. The company's revenue reached 1,075.5 million dirhams, reflecting an 8.4% increase in reported currency and a 9.0% increase in constant currency compared to the previous year. Net profit continued its stable upward trend, reaching 173.3 million dirhams (including 111.2 million dirhams as a one-time exceptional capital gain), compared to 44.9 million dirhams in the previous year (including 37.6 million dirhams as a one-time exceptional capital gain).
